Skip to main
PEPG
PEPG logo

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 60%
Buy 20%
Hold 0%
Sell 20%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned positively in the biotechnology sector, supported by its Enhanced Delivery Oligonucleotide platform, which aims to revolutionize the treatment of severe neuromuscular and neurologic diseases. The company's pipeline, featuring products like PGN-EDO51 and PGN-EDODM1, indicates significant potential for advancement, particularly as multi-dose data is anticipated to reveal a favorable risk/benefit profile. Currently trading at approximately $4 per share, analysts note that the stock presents meaningful upside potential, especially in light of projected valuation adjustments based on future clinical data results.

Bears say

PepGen Inc's financial outlook is negatively affected by a recent decrease in the target share price, which has been revised downwards to $8 per share due to concerns about the company's ability to execute commercially and meet performance expectations. Additionally, there is a significant risk that failure to access capital markets could lead to delays or even termination of ongoing development campaigns, adversely impacting the company's pipeline of oligonucleotide therapeutics. This combination of potential execution challenges and financial constraints creates a bleak perspective for investors regarding the future performance of PepGen's stock.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Buy. 60% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.